Peer-reviewedCC BYMolecular Biomedicine
Recent advances in antituberculosis drugs and therapeutics: from mechanistic breakthroughs to clinical translation
- 1Wuhan, Hubei 430030 China
- 2Tianjin, 300071 China
Related
- AMPK-Directed Therapeutics for MASLD: Mechanistic Rationale, Activator Classes, and Clinical Translation
- Breast Cancer Stem Cell-Associated Extracellular Vesicles: Bioengineering Advances in Source-Resolved Isolation, Mechanistic Validation, and Clinical Translation
- Advances in catalytic hydrogen storage materials: progress, breakthroughs, and challenges toward scalable applications.
- Research advances and clinical management of drug interactions between voriconazole and antituberculosis agents
- AI-driven multi-omics biomarkers in precision breast cancer therapeutics: from discovery to clinical translation
BibTeX
@article{pan2026recent,
title = {{Recent advances in antituberculosis drugs and therapeutics: from mechanistic breakthroughs to clinical translation}},
author = {Zhixiang Pan and Guan Liu and Yuehua Li and Hegui Yan and Yu Peng and Yiyi Wang and Hongri Gong and Juan Du and Shuang Wei},
journal = {Molecular Biomedicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13653915},
note = {CC BY},
}
RIS
TY - JOUR
TI - Recent advances in antituberculosis drugs and therapeutics: from mechanistic breakthroughs to clinical translation
AU - Zhixiang Pan
AU - Guan Liu
AU - Yuehua Li
AU - Hegui Yan
AU - Yu Peng
AU - Yiyi Wang
AU - Hongri Gong
AU - Juan Du
AU - Shuang Wei
PY - 2026
DA - 2026/10/10
JO - Molecular Biomedicine
UR - https://europepmc.org/article/PMC/PMC13653915
SN - 2662-8651
ER -